Which hedge funds own ABUS? ARBUTUS BIOPHARMA CORP, Q2 2026 13F holders
Healthcare · Open on the interactive board
5 of the hedge funds tracked by WhaleCreep disclosed a position in ABUS (ARBUTUS BIOPHARMA CORP) in their Q2 2026 13F filings, worth $51.0m in total. The largest holder by portfolio weight is Rubric Capital Management at 0.3% of its book. 2 exited: Avidity Partners, Millennium Management.
5tracked managers holding
0opened this quarter
2exited this quarter
Which hedge funds hold ABUS? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Rubric Capital Management | Q2 2026 | 0.3% | $36.2m | 7,532,937 | 14% | added |
| Woodline Partners | Q2 2026 | 0.0% | $11.0m | 2,281,856 | 14% | added |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $1.8m | 381,863 | 167% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $1.9m | 404,696 | -40% | reduced |
| First Manhattan | Q2 2026 | 0.0% | $67.2k | 14,000 | 0% | held |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Avidity Partners | 2.2% | $562.5k |
| Millennium Management | 0.0% | $2.9m |
How has hedge fund ownership of ABUS changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 5 | $51.0m |
| Q1 2026 | 7 | $46.1m |
| Q4 2025 | 4 | $18.5m |
| Q3 2025 | 3 | $17.0m |
| Q2 2025 | 3 | $12.6m |
| Q1 2025 | 3 | $15.2m |
| Q4 2024 | 3 | $8.7m |
| Q3 2024 | 3 | $9.1m |
| Q2 2024 | 3 | $8.1m |
| Q1 2024 | 2 | $10.5m |
| Q4 2023 | 3 | $12.1m |
| Q3 2023 | 2 | $9.6m |
| Q2 2023 | 4 | $14.3m |
| Q1 2023 | 4 | $21.6m |
| Q4 2022 | 2 | $8.2m |
| Q3 2022 | 1 | $87.0k |
Counts every tracked manager that disclosed ABUS in that quarter's filing, including managers that have since stopped filing.